Contents

Search


diatrizoate sodium (Hypaque)

Tradename: Hypaque. Indications: 1) cerebral angiography 2) urography - cystourethrography 3) aortography 4) arteriography 5) splenoportography 6) examination of the GI tract (powder) 7) computerized tomography 8) intravenous pyelography 9) cholangiography 10) hysterosalphingography 11) venography Contraindications: Pregnancy category: C Dosage: Injection: 25% (300 mL), 50% (20 mL, 30 mL, 50 mL) Adverse effects: 1) anaphylactoid reaction 1-10% 2) (see diatrizoate)

Interactions

drug adverse effects of contrast agents

General

diatrizoate pharmacologic combination

Database Correlations

PUBCHEM correlations

References

  1. Kaiser Permanente Northern California Regional Drug Formulary, 1998
  2. Deprecated Reference